Juan Camilo Ferreira

Biography

Juan Camilo Arjona Ferreira joined Myovant as Chief Medical Officer in July 2017. Dr. Arjona Ferreira was previously Senior Vice President, Clinical Development at Shionogi Inc. At Shionogi, Dr. Arjona Ferreira was responsible for leading the company’s US Clinical Development organization and he served on the company’s US Senior Leadership Team and the Global Scientific Committee. Prior to joining Shionogi, Dr. Arjona Ferreira spent over a decade at Merck & Co. where he was Executive Director of Clinical Research in Women’s Health. At Merck, he chaired the product development teams for all programs in contraception and women’s health. Dr. Arjona Ferreira earned his M.D. and completed his postgraduate specialist training in Obstetrics and Gynecology at Colegio Mayor del Rosario in Bogota, Colombia. Juan Camilo Arjona Ferreira joined Myovant as Chief Medical Officer in July 2017. Dr. Arjona Ferreira was previously Senior Vice President, Clinical Development at Shionogi Inc. At Shionogi, Dr. Arjona Ferreira was responsible for leading the company’s US Clinical Development organization and he served on the company’s US Senior Leadership Team and the Global Scientific Committee. Prior to joining Shionogi, Dr. Arjona Ferreira spent over a decade at Merck & Co. where he was Executive Director of Clinical Research in Women’s Health. At Merck, he chaired the product development teams for all programs in contraception and women’s health. Dr. Arjona Ferreira earned his M.D. and completed his postgraduate specialist training in Obstetrics and Gynecology at Colegio Mayor del Rosario in Bogota, Colombia.

Research Interest

Pharmaceutical Analysis and Quality Assurance  Industrial Pharmacy Clinical Pharmacy  Pharmaceutical Administration Medicinal Chemistry  Drug Discovery and Development